PEOPLE - Cardiogenesis makes appointment:
This article was originally published in Clinica
Cardiogenesis (Foothill Ranch, California), a developer of products for the treatment of angina, has appointed William Abbott as company vice-president, CFO, secretary and treasurer. Mr Abbott has over 27 years international corporate experience, including several senior financial and management roles. He was most recently vice-president of finance, and treasurer of California-based Newport Corporation, manufacturer of precision components and systems for application in laser and optical technologies.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.